DJ Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slid 1.11% to $8.90 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.35% to 51,848.90 and the NASDAQ Composite Index falling 0.43% to 25,476.64.
Novavax Inc. closed 25.65% short of its 52-week high of $11.97, which the company reached on February 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 0.80% to $241.00, Pfizer Inc. $(PFE)$ fell 2.75% to $24.04, and Merck & Co. Inc. $(MRK)$ rose 0.84% to $120.60.
Trading volume (3.5 M) remained 1.4 million below its 50-day average volume of 4.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 24, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 24, 2026 17:26 ET (21:26 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments